Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Radiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot Study

Study ID: NCT07376837
Start Date: 2026-02-05
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Radiofrequency Ablation of Papillary Thyroid Cancer

VIVA combo RF Generator with Coagulation Electrode

Sponsor

University Health Network, Toronto

Source: clinicaltrials.gov

Share:
Add to list

Empathy and Virtual Reality (VR)

Study ID: NCT07314788
Start Date: 2026-02-15
End Date: 2027-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

110

Intervention / Treatment

Fear-inducing Virtual Reality (VR) experience

Neutral Virtual Reality (VR) experience

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

Effect of Cuff Pressure Assessment Methods on Postoperative Complications in Breast Surgery

Study ID: NCT07341646
Start Date: 2026-03-01
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Continuous Cuff Pressure Indicator

Manual Cuff Pressure Manometer

Minimal Occlusive Volume Technique

Sponsor

Izmir Katip Celebi University

Source: clinicaltrials.gov

Share:
Add to list

Tele-Exercise for MERP

Study ID: NCT07018466
Start Date: 2026-07-01
End Date: 2030-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Tele-exercise

Standard of Care

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Study ID: NCT07326566
Start Date: 2026-04
End Date: 2029-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

162

Intervention / Treatment

silevertinib in combination with temozolomide

temozolomide (TMZ)

Sponsor

Black Diamond Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in CLDN18.2+ Pancreatic Cancer

Study ID: NCT07383922
Start Date: 2026-02-28
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

524

Intervention / Treatment

FG-M108

nab paclitaxel

Gemcitabine (GEM)

Placebo for FG-M108

Sponsor

FutureGen Biopharmaceutical (Beijing) Co., Ltd

Source: clinicaltrials.gov

Share:
Add to list

CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)

Study ID: NCT04933422
Start Date: 2027-01
End Date: 2029-07
Study Type

Interventional

Study Phase

Phase1

No. of Participants

72

Intervention / Treatment

As a spot

Sponsor

Crimson Biopharm Inc.

Source: clinicaltrials.gov

Share:
Add to list

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

Study ID: NCT07012031
Start Date: 2026-08-07
End Date: 2027-06-14
Study Type

Interventional

Study Phase

Phase2

No. of Participants

37

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Echocardiography Test

Magnetic Resonance Imaging

Multigated Acquisition Scan

Sotorasib

Trastuzumab Deruxtecan

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Evaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers

Study ID: NCT07290673
Start Date: 2026-04-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

124

Intervention / Treatment

FoundationDRS Solo

Standard of Care

Sponsor

Samaritan Biologics

Source: clinicaltrials.gov

Share:
Add to list

Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis

Study ID: NCT07376512
Start Date: 2026-03-01
End Date: 2030-03-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

378

Intervention / Treatment
Sponsor

Georges Francois Leclerc Center

Source: clinicaltrials.gov

Share:
Add to list